Literature DB >> 6712870

The psychological side effects of acebutolol and atenolol.

M J Lewis, D M Jones, A M Dart, A H Henderson.   

Abstract

We have measured the psychological effects of acebutolol and atenolol in sixteen patients with essential hypertension. The drugs were administered in a randomized, placebo-controlled, double-blind manner, in single daily doses of 100 mg atenolol, 400 mg acebutolol or placebo for periods of 6 weeks, each drug period being separated by a placebo period. At each 2 weekly clinic visit, a questionnaire designed for assessment of state anxiety and state arousal was administered for self-completion. Arousal was significantly reduced by atenolol over the whole 6 weeks of administration. It was not affected by acebutolol. Anxiety was significantly reduced by acebutolol but only at the first of the three 2 weekly assessments on treatment. It was not affected by atenolol. Differences in the psychological effects of these two beta-adrenoceptor blockers are discussed in terms of their lipid solubility and haemodynamic effects.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712870      PMCID: PMC1463380          DOI: 10.1111/j.1365-2125.1984.tb02356.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  Measurement of activation through self-report.

Authors:  R E Thayer
Journal:  Psychol Rep       Date:  1967-04

2.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 3.  The clinical importance of cardioselectivity and lipophilicity in beta blockers.

Authors:  J M Cruickshank
Journal:  Am Heart J       Date:  1980-08       Impact factor: 4.749

4.  Effect of oxprenolol on stage-fright in musicians.

Authors:  I M James; D N Griffith; R M Pearson; P Newbury
Journal:  Lancet       Date:  1977-11-05       Impact factor: 79.321

5.  Central effects of the beta-adrenergic blocking agent acebutolol. A quantitative EEG study using normalised slope descriptors.

Authors:  K Kayed; O B Godtlibsen
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

6.  Oxprenolol in the treatment of examination stress.

Authors:  G Krishnan
Journal:  Curr Med Res Opin       Date:  1976       Impact factor: 2.580

  6 in total
  3 in total

1.  Anxiolytic effects of acebutolol and atenolol in healthy volunteers with induced anxiety.

Authors:  S G Kilminster; M J Lewis; D M Jones
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 2.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

Review 3.  Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.

Authors:  B N Singh; W R Thoden; A Ward
Journal:  Drugs       Date:  1985-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.